When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MDWD - MediWound launches mid-stage study of EscharEx in venous leg ulcers
MediWound Ltd.
MediWound (MDWD-1.2%) initiates a Phase 2 clinical trial evaluating EscharEx, a topical biologic designed to enzymatically debride (remove dead tissue) chronic wounds, for the treatment of venous leg ulcers.
More news on: MediWound Ltd., Healthcare stocks news,